0
0.5
1
1.5
2+
Mortality
86%
Improvement
Relative Risk
Hospitalization
93%
primary
Ivermectin for COVID-19 Hazan et al. LATE TREATMENT
Is late treatment with ivermectin + combined treatments beneficial for COVID-19?
Retrospective study in the USA
Synthetic control arm
c19ivm.org
Hazan et al., Future Microbiology, Jul 2021
Favors ivermectin
Favors control